A Bayesian approach to improved estimation of causal effect predictiveness for a principal surrogate endpoint
From MaRDI portal
Publication:4649074
DOI10.1111/J.1541-0420.2011.01736.XzbMATH Open1272.62106OpenAlexW2118135341WikidataQ41812285 ScholiaQ41812285MaRDI QIDQ4649074FDOQ4649074
Authors: Corwin Matthew Zigler, Thomas R. Belin 
Publication date: 19 November 2012
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3860118
Recommendations
- Evaluating Candidate Principal Surrogate Endpoints
- A Bayesian approach to surrogacy assessment using principal stratification in clinical trials
- Comparing biomarkers as principal surrogate endpoints
- Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials
- Principal causal effect identification and surrogate end point evaluation by multiple trials
Cites Work
- Inference from iterative simulation using multiple sequences
- Principal stratification in causal inference
- Sampling-Based Approaches to Calculating Marginal Densities
- Evaluating Candidate Principal Surrogate Endpoints
- Bayesian inference for causal effects: The role of randomization
- Interval estimation for messy observational data
- Principal Stratification for Causal Inference With Extended Partial Compliance
- A Bayesian approach to surrogacy assessment using principal stratification in clinical trials
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model
- Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials
Cited In (8)
- Causal inference: a missing data perspective
- Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time
- An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference
- A Bayesian approach to surrogacy assessment using principal stratification in clinical trials
- Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm
- Causal measures of the treatment effect captured by candidate surrogate endpoints
- Defining estimands in clinical trials: a unified procedure
- Identification of causal effects within principal strata using auxiliary variables
This page was built for publication: A Bayesian approach to improved estimation of causal effect predictiveness for a principal surrogate endpoint
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4649074)
